These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 6158467)
1. The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma. Lebreton de Vonne T; Mouray H Int J Biochem; 1980; 12(3):479-84. PubMed ID: 6158467 [No Abstract] [Full Text] [Related]
2. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Downing MR; Bloom JW; Mann KG Biochemistry; 1978 Jun; 17(13):2649-53. PubMed ID: 79421 [TBL] [Abstract][Full Text] [Related]
3. [Physiological anticoagulants. Current data on the composition, function and clinical value]. Barkagan ZS; Bishevskii KM Lab Delo; 1978; (10):579-87. PubMed ID: 81906 [No Abstract] [Full Text] [Related]
4. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome]. Campo G; Modena N; Gallo A; Ciaffoni S Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802 [TBL] [Abstract][Full Text] [Related]
5. Measurement of antithrombin III, alpha 2-macroglobulin and alpha 1-antitrypsin in patients with deep venous thrombosis and pulmonary embolism. de Boer AC; van Riel LA; den Ottolander GJ Thromb Res; 1979; 15(1-2):17-25. PubMed ID: 90398 [No Abstract] [Full Text] [Related]
6. Thrombin inhibitors in women on oral contraceptives. Guagnellini E; Bertolini G; Cappelletti M; Colombo G Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217 [TBL] [Abstract][Full Text] [Related]
7. [Clinical problems of the natural coagulation and fibrinolysis inhibitors--introduction (author's transl)]. Aoki N Rinsho Ketsueki; 1978 Jul; 19(7):917-9. PubMed ID: 81326 [No Abstract] [Full Text] [Related]
8. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma. de Vonne TL; Mouray H Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495 [TBL] [Abstract][Full Text] [Related]
9. [Functional properties of thrombocytes and inhibitors of proteolytic enzymes of the blood in patients with acute forms of ischemic heart disease]. Kakuliia MSh; Panchenko VM Kardiologiia; 1988 May; 28(5):42-6. PubMed ID: 2457730 [TBL] [Abstract][Full Text] [Related]
10. The contribution of plasma protease inhibitors to antiplasmin activity in man. Crawford GP; Ogston D; Douglas AS Clin Sci Mol Med; 1976 Aug; 51(2):215-8. PubMed ID: 60190 [TBL] [Abstract][Full Text] [Related]
11. Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins. Di Micco B; Di Micco P; Lepretti M; Stiuso P; Donnarumma G; Iovene MR; Capasso R; Tufano MA Int J Exp Pathol; 2005 Aug; 86(4):241-5. PubMed ID: 16045546 [TBL] [Abstract][Full Text] [Related]
12. Familial thrombosis due to antithrombin III deficiency in a Greek family. Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891 [TBL] [Abstract][Full Text] [Related]
13. [Progressive antithrombin activity in rabbit plasma. Role of alpha macroglobulins]. Lebreton de Vonne T; Versavel C; Mouray H C R Acad Hebd Seances Acad Sci D; 1978 May; 286(19):1395-7. PubMed ID: 78775 [TBL] [Abstract][Full Text] [Related]
14. A new assay for the measurement of total progressive antithrombin. Lane JL; Bird P; Rizza CR Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064 [TBL] [Abstract][Full Text] [Related]